In 2012 UBC CPD received the Royal College Accredited CPD Provider Innovation Award for This Changed My Practice.
Drs. Elina Liu, Erin Morley, and Anna Rahmani
Dr. Elina Liu is a General Internal Medicine fellow at the University of British Columbia. She completed her medical school training at Queen's University in 2018, and her internal medicine residency at UBC in 2021. She is planning on pursuing additional training in Thrombosis in the 2022-2023 academic year. See Dr. Elina Liu's Profile”
By Drs. Elina Liu, Erin Morley, and Anna Rahmani on November 15, 2021
Each year, 1 in 6 patients with atrial fibrillation, or an estimated 6 million patients worldwide, will require perioperative anticoagulant management. An increasing number of atrial fibrillation patients are using direct oral anticoagulants (DOACs) in place of warfarin for stroke prevention. However, there has been uncertainty regarding perioperative management of DOACs, with significant variability noted in clinical practice. This can lead to potential harm with an increased risk of thrombosis if a DOAC is held for too long versus increased risk of post-operative bleeding if interruption intervals are too short.